BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2319645)

  • 1. Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment.
    Suzich JA; Kakach LT; Collett MS
    J Virol; 1990 Apr; 64(4):1549-55. PubMed ID: 2319645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression.
    Kakach LT; Wasmoen TL; Collett MS
    J Virol; 1988 Mar; 62(3):826-33. PubMed ID: 3339714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation.
    Kakach LT; Suzich JA; Collett MS
    Virology; 1989 Jun; 170(2):505-10. PubMed ID: 2728348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rift Valley fever virus M segment: cell-free transcription and translation of virus-complementary RNA.
    Suzich JA; Collett MS
    Virology; 1988 Jun; 164(2):478-86. PubMed ID: 3285574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins.
    Wasmoen TL; Kakach LT; Collett MS
    Virology; 1988 Sep; 166(1):275-80. PubMed ID: 3046119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete sequences of the glycoproteins and M RNA of Punta Toro phlebovirus compared to those of Rift Valley fever virus.
    Ihara T; Smith J; Dalrymple JM; Bishop DH
    Virology; 1985 Jul; 144(1):246-59. PubMed ID: 2998043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins.
    Schmaljohn CS; Parker MD; Ennis WH; Dalrymple JM; Collett MS; Suzich JA; Schmaljohn AL
    Virology; 1989 May; 170(1):184-92. PubMed ID: 2655274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus.
    Collett MS; Purchio AF; Keegan K; Frazier S; Hays W; Anderson DK; Parker MD; Schmaljohn C; Schmidt J; Dalrymple JM
    Virology; 1985 Jul; 144(1):228-45. PubMed ID: 2998042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses.
    Giorgi C; Accardi L; Nicoletti L; Gro MC; Takehara K; Hilditch C; Morikawa S; Bishop DH
    Virology; 1991 Feb; 180(2):738-53. PubMed ID: 1846496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of baculovirus-expressed Rift Valley fever virus glycoproteins synthesized in insect cells.
    Takehara K; Morikawa S; Bishop DH
    Virus Res; 1990 Nov; 17(3):173-90. PubMed ID: 2077783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus.
    Takehara K; Min MK; Battles JK; Sugiyama K; Emery VC; Dalrymple JM; Bishop DH
    Virology; 1989 Apr; 169(2):452-7. PubMed ID: 2705307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA of the M segment RNA of Rift Valley fever virus.
    Collett MS
    Virology; 1986 May; 151(1):151-6. PubMed ID: 3962188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete nucleotide sequence of the M RNA segment of Uukuniemi virus encoding the membrane glycoproteins G1 and G2.
    Rönnholm R; Pettersson RF
    Virology; 1987 Sep; 160(1):191-202. PubMed ID: 3629974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome.
    Lara E; Billecocq A; Leger P; Bouloy M
    J Virol; 2011 Dec; 85(23):12134-45. PubMed ID: 21917943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression strategy of the M genome segment of Hantaan virus.
    Kamrud KI; Schmaljohn CS
    Virus Res; 1994 Jan; 31(1):109-21. PubMed ID: 8165863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus.
    Keegan K; Collett MS
    J Virol; 1986 May; 58(2):263-70. PubMed ID: 2422392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hantaan virus M-segment glycoproteins G1 and G2 can be expressed independently.
    Pensiero MN; Hay J
    J Virol; 1992 Apr; 66(4):1907-14. PubMed ID: 1548747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.
    Phoenix I; Lokugamage N; Nishiyama S; Ikegami T
    Viruses; 2016 May; 8(6):. PubMed ID: 27231931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors.
    Filone CM; Heise M; Doms RW; Bertolotti-Ciarlet A
    Virology; 2006 Dec 5-20; 356(1-2):155-64. PubMed ID: 16945399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates.
    Accardi L; Prehaud C; Di Bonito P; Mochi S; Bouloy M; Giorgi C
    J Gen Virol; 2001 Apr; 82(Pt 4):781-785. PubMed ID: 11257182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.